Related Experiment Video

Updated: Apr 18, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Lack of association between MIF gene -173G>C polymorphism with multiple sclerosis

Betul Cevik1, Serbulent Yigit2, Nevin Karakus2

  • 1Gaziosmanpasa University Faculty of Medicine, Department of Neurology, Tokat, Turkey cevikbetul78@hotmail.com.

In Vivo (Athens, Greece)
|January 21, 2015
PubMed
Abstract

Insights

This study found no link between the MIF -173G>C gene variant and multiple sclerosis (MS) susceptibility in Turkish patients. Further research is needed to understand the genetic factors contributing to MS.

Area of Science:

  • Genetics
  • Immunology
  • Neurology

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Genetic factors play a role in MS susceptibility, but specific gene associations require further investigation.
  • The Macrophage Migration Inhibitory Factor (MIF) gene is a potential candidate due to its role in inflammation.

Purpose of the Study:

  • To investigate the association between the MIF -173G>C promoter polymorphism (rs755622) and MS risk in a Turkish population.
  • To determine if this polymorphism correlates with clinical or demographic characteristics of MS patients.

Main Methods:

  • A case-control study was conducted with 153 MS patients and 210 healthy controls.
  • Genomic DNA was extracted and analyzed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) for the MIF -173G>C polymorphism.

Main Results:

  • No statistically significant differences in allele or genotype frequencies of the MIF -173G>C polymorphism were observed between MS patients and controls.
  • No association was found between the MIF -173G>C polymorphism and MS susceptibility when analyzed using different genotype comparisons.
  • The polymorphism did not show a significant association with clinical and demographic features of MS patients.

Conclusions:

  • The MIF -173G>C polymorphism is not associated with MS susceptibility in the Turkish population studied.
  • These findings suggest that this specific MIF gene variant does not contribute to the risk of developing MS in this ethnic group.
  • Further genetic studies are warranted to identify other potential risk factors for MS.
Keywords:
-173G>C gene polymorphismMultiple sclerosismacrophage migration inhibitory factor (MIF)promoter polymorphismsusceptibility

More Related Videos

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.6K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.1K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
2
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.2K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.4K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.2K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.1K